Tiagabine

Chemical formula: C₂₀H₂₅NO₂S₂  Molecular mass: 375.548 g/mol  PubChem compound: 60648

Therapeutic indications

Tiagabine is indicated for:

Partial seizures

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Tiagabine is an anti-epileptic drug indicated as add-on therapy for partial seizures with or without secondary generalisation where control is not achieved by optimal doses of at least one other anti-epileptic drug.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Tiagabine is contraindicated in the following cases:

Severely impaired liver function

Hepatic failure stage IV

St. John's Wort (Hypericum perforatum)

Hypericum perforatum (St John's Wort)

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2022: GABITRIL Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈